← 產業報告目錄

Pharmaceutical CRDMO Services Market Size, Share & Trends Analysis Report By Type (Small molecular CRDMO service, Middle molecular CRDMO service, Large molecular CRDMO service, By Application (Oncology, Central Nervous System (CNS), Cardiovascular, Infectious Diseases, Hematology, Vaccine), By Region, And By Segment Forecasts, 2024-2031.

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-28頁數 180報告編號 INSIGHTACE-856fb100e1

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

With a 2023 valuation of USD 114.8 billion, the global Pharmaceutical CRDMO Services Market is set to progress to USD 266.7 billion by 2031, demonstrating a CAGR of 11.3% during the 2024–2031 forecast window. At its core, Pharmaceutical CRDMO Services pertains to landscape are expandingly turning to these solutions to meet contemporary demands. Growth is underpinned by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Pharmaceutical CRDMO Service Market Snapshot Chapter 4. Global Pharmaceutical CRDMO Service Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis 5.1. by Type & Market Share, 2019 & 2031 5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type: 5.2.1. Small Molecule CRDMO Service 5.2.2. Middle Molecule CRDMO Service 5.2.3. Large Molecule CRDMO Service Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis 6.1. by Application & Market Share, 2019 & 2031 6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application: 6.2.1. Oncology 6.2.2. Infectious Disease 6.2.3. Neurology 6.2.4. Immunology 6.2.5. Hematology 6.2.6. Vaccine Chapter 7. Pharmaceutical CRDMO Service Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031 7.1.2. North America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.1.3. North America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.2. Europe 7.2.1. Europe Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031 7.2.2. Europe Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.2.3. Europe Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.3. Asia Pacific 7.3.1. Asia Pacific Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031 7.3.2. Asia Pacific Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.3.3. Asia Pacific Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.4. Latin America 7.4.1. Latin America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031 7.4.2. Latin America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.4.3. Latin America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.5. Middle East & Africa 7.5.1. Middle East & Africa Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031 7.5.2. Middle East & Africa Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.5.3. Middle East & Africa Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. BioDuro-Sundia 8.2.2. Sai Life Sciences 8.2.3. Icosagen 8.2.4. WuXi Biologics 8.2.5. WuXi AppTec 8.2.6. Esco Aster 8.2.7. Jubilant Biosys 8.2.8. Syngene International 8.2.9. Chemveda 8.2.10. Ardena Holding 8.2.11. Eurofins 8.2.12. Jiangsu HUAYI Technology Co., Ltd.

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們